| For: |
Pai V, Pai N. Randomized, double-blind, comparative study of dexrabeprazole 10 mg |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i30/4100.htm |
| Number | Citing Articles |
| 1 |
David Armstrong, Daniel Sifrim. New Pharmacologic Approaches in Gastroesophageal Reflux Disease. Gastroenterology Clinics of North America 2010; 39(3) doi: 10.1016/j.gtc.2010.08.019
|
| 2 |
Miri Kim, Su Kyung Yu, Quoc-Ky Truong, Xuan-Lan Mai, Hyun Kyu Chung, Jong-Seong Kang, Kyeong Ho Kim. Determination of rabeprazole enantiomers in commercial tablets using immobilized cellulose-based stationary phase. Archives of Pharmacal Research 2017; 40(3) doi: 10.1007/s12272-017-0896-z
|
| 3 |
Yu Kyung Cho, Myung-Gyu Choi, Hyojin Park, Ji Won Kim, Dong Ho Lee, Kwang Hyun Ko, Sang Gyun Kim, Hwoon-Yong Jung, Su Jin Hong, Yong Chan Lee, Si Hyung Lee. Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease: A Phase III Placebo-controlled Trial. Journal of Neurogastroenterology and Motility 2021; 27(2) doi: 10.5056/jnm19053
|
| 4 |
L N Rogoza, N F Salakhutdinov. Anti-ulcer agents: chemical aspect of solving the problem. Russian Chemical Reviews 2015; 84(1) doi: 10.1070/RCR4430
|
| 5 |
Ozgur KARCIOGLU, Selman YENİOCAK, Mandana HOSSEINZADEH, Seckin Bahar SEZGIN. Abdominal Pain: Essential Diagnosis and Management in Acute Medicine. 2022; doi: 10.2174/9789815051780122010005
|
| 6 |
Na Cao, Lei Liu, Yuan-bin Hao, Li-li Sun, Qiao-gen Zou, Xing-ling Ma, Kai-he Xiong. Simultaneous determination of rabeprazole enantiomers and their four metabolites after intravenous administration in beagle dogs by a stereoselective HPLC-MS/MS method and its application in pharmacokinetic studies. Analytical Methods 2016; 8(6) doi: 10.1039/C5AY03200H
|
| 7 |
Quan Zhou, Xiao-Feng Yan, Wen-Sheng Pan, Su Zeng. Is the required therapeutic effect always achieved by racemic switch of proton-pump inhibitors?. World Journal of Gastroenterology 2008; 14(16): 2617-2619 doi: 10.3748/wjg.14.2617
|
| 8 |
Kenneth R. DeVault, Nicholas J. Talley. Insights into the future of gastric acid suppression. Nature Reviews Gastroenterology & Hepatology 2009; 6(9) doi: 10.1038/nrgastro.2009.125
|
| 9 |
Tae Jin Lee, Dohyun Kim, Jae Cheon Kim, Si Won Ro, Dong Hee Na. Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets. Journal of Pharmaceutical Investigation 2023; 53(2) doi: 10.1007/s40005-022-00602-x
|
| 10 |
Yu Kyung Cho, Myung-Gyu Choi, Young-Tae Bak, Poong-Lyul Rhee, Sang Gyun Kim, Hoon-Yong Jung, Sang Young Seol. Efficacy of S-Pantoprazole 20 mg Compared with Pantoprazole 40 mg in the Treatment of Reflux Esophagitis: A Randomized, Double-Blind Comparative Trial. Digestive Diseases and Sciences 2012; 57(12) doi: 10.1007/s10620-012-2297-y
|
| 11 |
Gergely Dombi, Levente Tyukodi, Máté Dobó, Gergely Molnár, Zsuzsanna Rozmer, Zoltán-István Szabó, Béla Fiser, Gergő Tóth. Enantioselective Binding of Proton Pump Inhibitors to Alpha1-Acid Glycoprotein and Human Serum Albumin—A Chromatographic, Spectroscopic, and In Silico Study. International Journal of Molecular Sciences 2024; 25(19) doi: 10.3390/ijms251910575
|
| 12 |
David Armstrong, Daniel Sifrim. New Pharmacologic Approaches in Gastroesophageal Reflux Disease. Thoracic Surgery Clinics 2011; 21(4) doi: 10.1016/j.thorsurg.2011.09.005
|
| 13 |
Rajendra Kanakia, Suresh Jain. Ten mg dexrabeprazole daily is as effective as 20 mg dexrabeprazole daily. World Journal of Gastroenterology 2008; 14(28): 4586-4587 doi: 10.3748/wjg.14.4586
Abstract(1078) |
Core Tip(970) |
Full Article(HTML)(2682)
|
Full Article (PDF)-533K(449)
|
Times Cited (0)
|
Total Visits (3651)
|
Open
|
| 14 |
Peter J Kahrilas, Colin W Howden, Nesta Hughes. Response of Regurgitation to Proton Pump Inhibitor Therapy in Clinical Trials of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 2011; 106(8) doi: 10.1038/ajg.2011.146
|
| 15 |
Shuchi Dixit, Rituraj Dubey, Ravi Bhushan. Normal and polar‐organic‐phase high‐performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro‐methylated cellulose‐based chiral stationary phase and determination of dexrabeprazole. Biomedical Chromatography 2014; 28(1) doi: 10.1002/bmc.2915
|
| 16 |
Stefano Pallotta, Fabio Pace, Silvia Marelli. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease. Expert Review of Gastroenterology & Hepatology 2008; 2(4) doi: 10.1586/17474124.2.4.509
|
| 17 |
Jianman Guo, Xiaoyuan Ma, Fanlong Bu, Jian Wang, Jie Sun, Rui Zhang. Improved quantitative determination of (R)- and (S)‐rabeprazole sodium and its metabolites in rat plasma by LC-MS/MS and its application to a toxicokinetic study. Journal of Chromatography B 2024; 1232 doi: 10.1016/j.jchromb.2023.123969
|
| 18 |
Sukhbir K Shahid.
Novel Anti
-Helicobacter Pylori
Therapies
. Pharmaceutical Patent Analyst 2014; 3(4) doi: 10.4155/ppa.14.27
|
| 19 |
Lu‐Ning Sun, Yi‐Wen Shen, Yu‐Wen Ying, Duo Li, Teng‐Fei Li, Xue‐Hui Zhang, Ping Zhao, Li Ding, Yong‐Qing Wang. Stereoselective pharmacokinetics of (R)‐(+)‐ and (S)‐(−)‐rabeprazole in human using chiral LC‐MS/MS after administration of rabeprazole sodium enteric‐coated tablet. Chirality 2018; 30(12) doi: 10.1002/chir.23022
|
| 20 |
Chong Su, Hong Yang, Xiangjun Meng, J. Paul Fawcett, Jianming Cao, Yan Yang, Jingkai Gu. Determination of rabeprazole enantiomers in dog plasma by supercritical fluid chromatography tandem mass spectrometry and its application to a pharmacokinetic study. Journal of Separation Science 2017; 40(4) doi: 10.1002/jssc.201601232
|
| 21 |
Zaahira Aumeeruddy-Elalfi, Ismaël Saïd Ismaël, Muzzammil Hosenally, Gokhan Zengin, Mohamad Fawzi Mahomoodally. Essential oils from tropical medicinal herbs and food plants inhibit biofilm formation in vitro and are non-cytotoxic to human cells. 3 Biotech 2018; 8(9) doi: 10.1007/s13205-018-1413-x
|
| 22 |
Tommy Andersson, Lars Weidolf. Stereoselective Disposition of Proton??Pump Inhibitors. Clinical Drug Investigation 2008; 28(5) doi: 10.2165/00044011-200828050-00001
|
| 23 |
Alex Mejia, Walter K Kraft. Acid peptic diseases: pharmacological approach to treatment. Expert Review of Clinical Pharmacology 2009; 2(3) doi: 10.1586/ecp.09.8
|
| 24 |
Long Nguyen, John Birk. Current and Prospective Pharmacotherapies in Gastroesophageal Reflux Disease. Clinical Medicine. Therapeutics 2009; 1 doi: 10.4137/CMT.S2744
|
| 25 |
Feng Liu, Chao Shou, Qiang Geng, Chen Zhao, Jianhe Xu, Huilei Yu. A Baeyer-Villiger monooxygenase from Cupriavidus basilensis catalyzes asymmetric synthesis of (R)-lansoprazole and other pharmaco-sulfoxides. Applied Microbiology and Biotechnology 2021; 105(8) doi: 10.1007/s00253-021-11230-0
|
| 26 |
Yan‐hui Gao, Jia‐xing Xu, Zhong‐xue Su, Li Song, Hong‐xiang Lou. The chiral bioconversion and preclinical pharmacokinetic analysis of (R)‐(+)‐rabeprazole in beagle dogs by HPLC and HPLC‐MS/MS. Biomedical Chromatography 2013; 27(11) doi: 10.1002/bmc.2932
|